1. Home
  2. BDTX vs VSTA Comparison

BDTX vs VSTA Comparison

Compare BDTX & VSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • VSTA
  • Stock Information
  • Founded
  • BDTX 2014
  • VSTA 1966
  • Country
  • BDTX United States
  • VSTA Brazil
  • Employees
  • BDTX N/A
  • VSTA N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • VSTA Other Consumer Services
  • Sector
  • BDTX Health Care
  • VSTA Real Estate
  • Exchange
  • BDTX Nasdaq
  • VSTA Nasdaq
  • Market Cap
  • BDTX 181.4M
  • VSTA 332.9M
  • IPO Year
  • BDTX 2020
  • VSTA 2020
  • Fundamental
  • Price
  • BDTX $3.16
  • VSTA $4.96
  • Analyst Decision
  • BDTX Strong Buy
  • VSTA
  • Analyst Count
  • BDTX 6
  • VSTA 0
  • Target Price
  • BDTX $12.50
  • VSTA N/A
  • AVG Volume (30 Days)
  • BDTX 840.0K
  • VSTA 32.5K
  • Earning Date
  • BDTX 11-04-2025
  • VSTA 11-06-2025
  • Dividend Yield
  • BDTX N/A
  • VSTA N/A
  • EPS Growth
  • BDTX N/A
  • VSTA N/A
  • EPS
  • BDTX 0.25
  • VSTA 1.09
  • Revenue
  • BDTX $70,000,000.00
  • VSTA $313,466,268.00
  • Revenue This Year
  • BDTX N/A
  • VSTA $11.22
  • Revenue Next Year
  • BDTX N/A
  • VSTA $13.43
  • P/E Ratio
  • BDTX $12.78
  • VSTA $4.56
  • Revenue Growth
  • BDTX N/A
  • VSTA 8.99
  • 52 Week Low
  • BDTX $1.20
  • VSTA $1.60
  • 52 Week High
  • BDTX $6.23
  • VSTA $5.49
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 58.90
  • VSTA 80.61
  • Support Level
  • BDTX $3.13
  • VSTA $4.35
  • Resistance Level
  • BDTX $3.43
  • VSTA $4.68
  • Average True Range (ATR)
  • BDTX 0.18
  • VSTA 0.22
  • MACD
  • BDTX 0.02
  • VSTA 0.05
  • Stochastic Oscillator
  • BDTX 63.51
  • VSTA 95.70

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About VSTA Vasta Platform Limited

Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.

Share on Social Networks: